Medical/Pharmaceuticals

AGC Biologics Expands Development Capacities for pDNA Services at Heidelberg Site

Expansion will help meet the growing demand for plasmid DNA offerings SEATTLE, June 30, 2020 /PRNewswire/ -- Committed to continuous innovation and expansion of its service offerings, AGC Biologics has announced the expansion of its pDNA Center of Excellence in Heidelberg, Germany. The global bi...

2020-06-30 21:00 598

Ajinomoto Bio-Pharma Services Introduces AJILITY Fast Track Platform for Drug Product Manufacturing

SAN DIEGO, June 30, 2020 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce the launch of AJILITY™, a flexible and agile drug product manufacturing platform, designed to ...

2020-06-30 20:10 497

One Drop Commended by Frost & Sullivan for Its Industry-leading Connected Glucose Meter and Smartphone Application

SANTA CLARA, California, June 30, 2020 /PRNewswire/ -- Based on its recent analysis of the North American diabetes data management platform market, Frost & Sullivan recognizesOne Drop with the 2020 North America Technology Innovation Leadership Award. One Drop's complete diabetes management platf...

2020-06-30 20:00 574

Zhejiang Hisun Pharmaceutical: COVID-19 Pandemic Brought Under Control in China With Favipiravir Showing Excellent Clinical Results

TAIZHOU, China, June 30, 2020 /PRNewswire/ -- COVID-19 has become a global pandemic.China's successful control of the pandemic has set a good example for other countries. Many have followedChina to take effective measures like enforcing lockdowns and wearing masks have all been proved to be effec...

2020-06-30 18:51 575

Release of Initial Attana Virus Analytics-AVA Testing Protocols

STOCKHOLM, June 30, 2020 /PRNewswire/ -- Attana has today released the initial technical protocols for AVA Antibody Testing and will make these available to all existing Attana customers. In close collaboration with Linnaeus University Attana application specialists have been performing studies ...

2020-06-30 15:42 434

Sweeping Workplace Changes Expected in a Post-pandemic World, Says Research From The Adecco Group

ZURICH, June 30, 2020 /PRNewswire/ -- * Workers demand greater flexibility after coronavirus, with a 50/50 split of remote and office time confirmed as the universal ideal * Questions raised over the hours-based contract, with 69% saying contracts should be based on results delivered rather t...

2020-06-30 15:00 541

Thrombosis Research Institute (TRI) Announce ETHIC Trial to Evaluate the Potential Benefits of Early Administration of LMWH in Patients with COVID-19

- Clinical trial will recruit approximately 1400 patients in 10 countries starting in July  - Participants will be randomised to receive the low molecular weight Heparin enoxaparin or current standard of care for up to 3 weeks from the time of diagnosis  - The study is supported through an inve...

2020-06-30 14:00 493

AOBiome Reports Successful Clinical Trials (Phase 2a in Adults and Phase 1b in Pediatrics) in Pruritus (Itch) Associated with Atopic Dermatitis: Initiates Phase 2b Clinical Trial in Adults

AOBiome's 576 patient Phase 2b trial commences patient enrollment CAMBRIDGE, Massachusetts, June 30, 2020 /PRNewswire/ -- AOBiome Therapeutics, Inc. ("AOBiome"), a leading clinical-stage microbiome company focusing on inflammation,  announced initiation of a Phase2b clinical trial in pruritus (i...

2020-06-30 13:00 457

MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR™ Sirolimus Drug Eluting Balloon

NYON, Switzerland, June 30, 2020 /PRNewswire/ -- MedAlliance has announced the award of its second CE Mark: SELUTION SLR™ 014 PTCA, a novel Sirolimus Drug Eluting Balloon (DEB), for the treatment of coronary arterial disease. This includes indications for both de-novo lesions as well as in-stent ...

2020-06-30 08:00 539

Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2020

Added 18,488 New Subscribers in 4Q20 4Q20 Revenues Increased by 19.2% YoY to RMB299.9 Million ($42.4 Million) 4Q20 Operating Income Increased by 68.1% YoY to RMB149.3 Million ($21.1 Million) Non-GAAP Operating Income Up 58.7% YoY to RMB161.7 Million ($22.8 Million) Conference Call to be Held on Jun...

2020-06-30 04:16 6252

RevImmune Announces Phase II Trial of the T-Cell Growth Factor CYT107 for COVID-19

Under Way in Europe Since May, In Preparation in the U.S.  Designated As An Urgent Public Health National Priority In U.K. BETHESDA, Maryland, June 29, 2020 /PRNewswire/ -- RevImmune, a privately held biotechnology company developing CYT107 immune therapy for infectious diseases and cancer, an...

2020-06-29 21:00 541

How to Recognize Side-Effects from Immunotherapy? New NCCN Guidelines for Patients can Help

PLYMOUTH MEETING, Pennsylvania, June 29, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) today announced the publication of  new NCCN Guidelines for Patients®: Immunotherapy Side Effects--Immune Checkpoint Inhibitors. Over the past decade, immunotherapy--a treatment that h...

2020-06-29 20:47 488

Wealth sharing campaign spreading in Suncheon to aid coronavirus victims

SUNCHEON, South Korea, June 29, 2020 /PRNewswire/ -- A wealth sharing campaign has been spreading in Suncheon, a city about 415 kilometers south ofSeoul, to support underprivileged citizens hit hard by the coronavirus outbreak. According to the municipality of Suncheon saidon Friday.

2020-06-29 14:58 600

Qiming's Portfolio Company Gan & Lee Pharmaceuticals Lands A-Shares Main Board

SHANGHAI, June 29, 2020 /PRNewswire/ -- Chinese insulin manufacturer Gan & Lee Pharmaceuticals (SHSE: 603087), Qiming's portfolio company today lands on the A-shares main board market. The issue price of Gan & Lee isRMB 63.32 per share. The stock opens atRMB 91.18 per share, up 44%, with a market...

2020-06-29 11:31 717

Worried Chinese away from home can turn to the 7885 Mustard Seed Helpline to ease their concerns during the COVID-19 pandemic

NEW TAIPEI CITY, June 29, 2020 /PRNewswire/ -- In response to the severe and negative effect that COVID-19 has had on people's physical and mental health, Taiwan-based social welfare organization, The Mustard Seed Mission, has launched an official account on Line, a popular social media applicatio...

2020-06-29 10:00 540

Philogen Received Clinical Trial Authorisation With Nidlegy in Nonmelanoma Skin Cancer

SIENA, Italy, June 26, 2020 /PRNewswire/ -- Philogen S.p.A., a privately-owned biotechnology company, is pleased to announce that the Swiss national competent authority Swissmedic issued the authorization to run a clinical phase II study in patients with locally advanced, not metastatic nonmelano...

2020-06-26 15:00 821

Medicom Announces UK Mask Manufacturing Facility in Alliance with British Government

MONTREAL, June 26, 2020 /PRNewswire/ -- The Medicom Group, ("Medicom"), one of the world's leading manufacturers of medical and respiratory masks, has announced the further expansion of its global footprint with the plan to open a new mask manufacturing facility in theUnited Kingdom this year.  ...

2020-06-26 03:54 757

OneDraw™ Blood Collection Device Receives the Red Dot Award for Outstanding Medical Device Product Design

MENLO PARK, California, June 25, 2020 /PRNewswire/ -- Drawbridge Health today announced that the OneDraw™ Blood Collection Device, the enabling technology for the FDA cleared OneDraw™ A1C Test System, has won the prestigiousRed Dot Award: Product Design 2020 in the category of Medical Devices. Th...

2020-06-25 21:00 840

ERBA Mannheim Launches CE Marked COVID-19 IgM Antibody ELISA

LONDON, June 25, 2020 /PRNewswire/ -- In response to the ongoing COVID-19 pandemic,Erba Mannheim today launched the ErbaLisa COVID-19 IgM ELISA kit for detection of IgM antibodies to SARS-CoV-2. IgM antibodies are produced first and detectable during disease onset, so using the new assay in comb...

2020-06-25 01:08 1080

Loss of Function Variant in FLT3 Strongly Increases the Risk of Autoimmune Thyroid Disease and Other Autoimmune Diseases

The combination of genomics, transcriptomics and proteomics sheds light on autoimmune thyroid disease, other autoimmune diseases and AML REYKJAVIK, Iceland, June 24, 2020 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from the Icelandic healthcare s...

2020-06-24 23:00 1335
12345 ... 175